HomeCompareFUNN vs MRK

FUNN vs MRK: Dividend Comparison 2026

FUNN yields 166666.67% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FUNN wins by $7.944525992890705e+28M in total portfolio value
10 years
FUNN
FUNN
● Live price
166666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.944525992890705e+28M
Annual income
$79,351,601,962,005,455,000,000,000,000,000,000.00
Full FUNN calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — FUNN vs MRK

📍 FUNN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFUNNMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FUNN + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FUNN pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FUNN
Annual income on $10K today (after 15% tax)
$14,166,666.67/yr
After 10yr DRIP, annual income (after tax)
$67,448,861,667,704,640,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, FUNN beats the other by $67,448,861,667,704,640,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FUNN + MRK for your $10,000?

FUNN: 50%MRK: 50%
100% MRK50/50100% FUNN
Portfolio after 10yr
$3.972262996445352e+28M
Annual income
$39,675,800,981,002,727,000,000,000,000,000,000.00/yr
Blended yield
99.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FUNN
No analyst data
Altman Z
-12.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FUNN buys
0
MRK buys
0
No recent congressional trades found for FUNN or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFUNNMRK
Forward yield166666.67%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$7.944525992890705e+28M$56.8K
Annual income after 10y$79,351,601,962,005,455,000,000,000,000,000,000.00$9,798.13
Total dividends collected$7.943912645651793e+28M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FUNN vs MRK ($10,000, DRIP)

YearFUNN PortfolioFUNN Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$16,677,367$16,666,666.67$11,206$366.19+$16.67MFUNN
2$25,995,051,428$25,977,206,645.90$12,650$502.35+$25995.04MFUNN
3$37,869,622,473,147$37,841,807,768,118.86$14,407$694.19+$37869622.46MFUNN
4$51,562,007,868,526,340$51,521,487,372,480,070.00$16,585$967.82+$51562007868.51MFUNN
5$65,615,852,892,511,920,000$65,560,681,544,092,600,000.00$19,342$1,363.89+$65615852892511.91MFUNN
6$78,042,202,741,585,770,000,000$77,971,993,778,990,800,000,000.00$22,913$1,947.19+$78042202741585760.00MFUNN
7$86,754,863,367,545,780,000,000,000$86,671,358,210,612,300,000,000,000.00$27,662$2,823.89+$86754863367545782272.00MFUNN
8$90,137,108,986,090,100,000,000,000,000$90,044,281,282,286,820,000,000,000,000.00$34,159$4,173.35+$9.01371089860901e+22MFUNN
9$87,530,810,188,407,730,000,000,000,000,000$87,434,363,481,792,600,000,000,000,000,000.00$43,337$6,308.80+$8.753081018840772e+25MFUNN
10$79,445,259,928,907,045,000,000,000,000,000,000$79,351,601,962,005,455,000,000,000,000,000,000.00$56,776$9,798.13+$7.944525992890705e+28MFUNN

FUNN vs MRK: Complete Analysis 2026

FUNNStock

Amfil Technologies Inc., through its subsidiary, Interloc-Kings Inc., provides landscape construction and snow removal services in Canada. It supplies and installs a range of interlocking stones for driveways, as well as offers fencing design services, and residential or commercial snow clearing services. The company, through its subsidiary, Snakes & Lagers Inc., operates a tabletop gaming bar and cafe located in Toronto, Ontario. In addition, Amfil Technologies Inc., through its other subsidiary, provides ozone based antimicrobial systems, which eliminate of bacteria, mold, and other pathogens from cannabis cultivation facilities, reducing or eliminating the need for harsh chemicals and pesticides during the cultivation process. The antimicrobial systems used to treat hydroponic reservoirs, plants, and surrounding surface areas during various stages of the grow cycle. Amfil Technologies, Inc. was founded in 2009 and is based in Markham, Canada.

Full FUNN Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FUNN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FUNN vs SCHDFUNN vs JEPIFUNN vs OFUNN vs KOFUNN vs MAINFUNN vs JNJFUNN vs ABBVFUNN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.